Clinical trial
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
NCT06222164 is registered in ClinicalTrials.gov with Invivoscribe, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
- Lead sponsor
- Invivoscribe, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 30, 2024
- Completion date
- June 30, 2027
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.